11th July 2023
24th May 2023
ElevateBio Announces $401 Million Series D Financing to Further Accelerate Growth
23rd May 2023
ReNAgade Therapeutics Launches with Over $300 Million in Series A Financing to Unlock the Limitless Potential of RNA Medicine
10th January 2023
NextPoint Therapeutics Announces $80 Million Series B Financing to Advance Novel Immuno-Oncology Programs
8th December 2022
Ansbert Gadicke on Revolutionary Therapies Rapidly Changing How We Treat Disease
8th December 2022
Ansbert Gadicke on the Role of Innovation in Biotech
9th September 2022
Photys Therapeutics Debuts with $75 Million Series A Funding to Advance New Class of Bifunctional Molecules to Modulate and Repair Disease-Driving Proteins
31st August 2022
Umoja’s Unified Approach to Exceeding the Limitations of Cell Therapy
25th August 2022
Aktis Oncology Raises $84 Million To Advance Novel Targeted Alpha Radiopharmaceuticals
18th August 2022